UBS Retains a Neutral Rating on Helen of Troy Limited (HELE)

Core Viewpoint - Helen of Troy Limited (NASDAQ:HELE) is recognized as one of the best beauty stocks to buy currently, despite facing challenges in its outlook and stock performance [1]. Group 1: Analyst Ratings and Price Targets - UBS has reduced its price target for Helen of Troy Limited from $25 to $22 while maintaining a Neutral rating, citing a better-than-expected third-quarter report but a challenging outlook ahead [2]. - Canaccord has also retained a Hold rating and lowered its price target from $23 to $22, noting sequential growth in revenues and adjusted earnings per share in line with expectations, but highlighting ongoing issues affecting profitability across the portfolio [3]. Group 2: Financial Performance - Helen of Troy Limited reported third-quarter results that exceeded revenue expectations, with notable sales increases in key brands such as OXO, Osprey, and Olive & June [3]. - The stock has declined by 8.63% year-to-date as of January 12, 2026, indicating potential concerns regarding its market performance [4]. Group 3: Market Position and Strategy - The company operates as a consumer products firm, offering creative products and solutions through a diverse portfolio of brands, which positions it well in the beauty and consumer goods market [4].